Health Economics Review

Fig. 3 | Health Economics Review

Fig. 3

From: Adjuvant treatment of high-risk melanoma – cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors

Fig. 3

ISSN: 2191-1991

Contact us

General enquiries: journalsubmissions@springernature.com